Indication
Vulvar HSIL
2 clinical trials
3 products
1 drug
Product
ArtesunateProduct
PlaceboClinical trial
A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL, a Randomised Placebo Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2028-12-01
Product
Gardasil 9Drug
Varlilumab